BRCA gene Carriers' immune system put to the test with flu shot
NCT ID NCT04499534
First seen Jun 27, 2026 · Last updated Jul 09, 2026 · Updated 2 times
Summary
This study checks how well the immune system works in healthy people with BRCA1 or BRCA2 gene mutations. About 50 adults over age 25 who carry these gene changes but have not had cancer will get a seasonal flu vaccine. Researchers will measure their antibody and immune cell responses to see if the mutation affects overall immune fitness.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRCA1 MUTATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a 'Baby Dose' of hormone pills prevent breast cancer?
- Toolkit aims to break the silence around inherited cancer genes
- Can online therapy calm BRCA1/2 women's fear of cancer return?
- New daily pill hopes to control advanced cancers
- New drug cocktail targets cancers with faulty DNA repair
- Can a website bring BRCA testing to more people?